These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 12205990

  • 1. [Candida albicans resistance and genotyping by randomly amplified polymorphic DNA method].
    Qian J, Zha GZ, Yu P.
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug 28; 25(4):327-30. PubMed ID: 12205990
    [Abstract] [Full Text] [Related]

  • 2. [Molecular epidemiologic surveillance and antifungal agent sensitivity of Candida albicans isolated from anesthesia intensive care units].
    Gülay Z, Ergon C, Ozkütük A, Yücesoy M, Biçmen M.
    Mikrobiyol Bul; 2002 Aug 28; 36(3-4):309-16. PubMed ID: 12838665
    [Abstract] [Full Text] [Related]

  • 3. Molecular epidemiology of Candida species isolated from urine at an intensive care unit.
    Ergon MC, Gülay Z.
    Mycoses; 2005 Mar 28; 48(2):126-31. PubMed ID: 15743431
    [Abstract] [Full Text] [Related]

  • 4. A longitudinal study of the change in resistance patterns and genetic relationship of oral Candida albicans from HIV-infected patients.
    McCullough M, Hume S.
    J Med Vet Mycol; 1995 Mar 28; 33(1):33-7. PubMed ID: 7650576
    [Abstract] [Full Text] [Related]

  • 5. [Screening of Candida albicans fluconazole--resistant mutation strains].
    Wang W, Zhang B, Wang X, Liu Y, Wang D.
    Wei Sheng Wu Xue Bao; 1997 Jun 28; 37(3):212-6. PubMed ID: 9863212
    [Abstract] [Full Text] [Related]

  • 6. Biotypes and randomly amplified polymorphic DNA (RAPD) profiles of subgingival Candida albicans isolates in HIV infection.
    Pizzo G, Giammanco GM, Pecorella S, Campisi G, Mammina C, D'Angelo M.
    New Microbiol; 2005 Jan 28; 28(1):75-82. PubMed ID: 15782629
    [Abstract] [Full Text] [Related]

  • 7. [Study on experimental induction of fluconazole resistance in Candida albicans].
    Zhu YN, Lu SM.
    Shi Yan Sheng Wu Xue Bao; 2004 Oct 28; 37(5):418-22. PubMed ID: 15636370
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A, Saddi M, Cardia MC, Borgna R, Sanna C, Saddi B, Maccioni E.
    J Antimicrob Chemother; 2005 May 28; 55(5):692-8. PubMed ID: 15772140
    [Abstract] [Full Text] [Related]

  • 9. [Fluconazole resistance in Candida albicans assayed by PCR fingerprinting with M13 prime].
    Wang YB, Wang H, Guo HY, Zhao YZ, Luo SQ.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec 28; 23(12):1303-6. PubMed ID: 14678897
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
    Mondello F, De Bernardis F, Girolamo A, Salvatore G, Cassone A.
    J Antimicrob Chemother; 2003 May 28; 51(5):1223-9. PubMed ID: 12668571
    [Abstract] [Full Text] [Related]

  • 11. Molecular analysis and dimorphism of azole-susceptible and resistant Candida albicans isolates.
    Costa CR, Hasimoto e Souza LK, Ataídes FS, Ferri PH, Costa MP, Fernanades Ode F, Silva Mdo R.
    Rev Soc Bras Med Trop; 2011 May 28; 44(6):740-4. PubMed ID: 22094708
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of different primers used for the genotyping of Candida albicans clinical isolates by randomly amplified polymorphic DNA method].
    Saran B, Karahan ZC, Ağirbaşli H, Tekeli A, Aksoy AM.
    Mikrobiyol Bul; 2008 Oct 28; 42(4):645-54. PubMed ID: 19149086
    [Abstract] [Full Text] [Related]

  • 13. [The relationship between Candida albicans 25S intron genotypes and antifungal susceptibilities].
    Balaban N, Karahan ZC, Mumcuoğlu I, Cayirli A, Kuştimur S.
    Mikrobiyol Bul; 2007 Apr 28; 41(2):245-51. PubMed ID: 17682711
    [Abstract] [Full Text] [Related]

  • 14. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.
    Liu XP, Fan SR, Bai FY, Li J, Liao QP.
    Mycoses; 2009 Jan 28; 52(1):24-8. PubMed ID: 18498300
    [Abstract] [Full Text] [Related]

  • 15. Biotypes, genotypes and ketoconazole susceptibility of Candida albicans isolates from a group of Thai AIDS patients.
    Teanpaisan R, Niyombandith M, Pripatnanant P, Sattayasanskul W.
    New Microbiol; 2008 Jul 28; 31(3):409-16. PubMed ID: 18843897
    [Abstract] [Full Text] [Related]

  • 16. [25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans].
    Zhang X, Liu ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr 25; 51(4):279-84. PubMed ID: 27116986
    [Abstract] [Full Text] [Related]

  • 17. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A, Sancak B, Arikan S.
    Mikrobiyol Bul; 2007 Apr 25; 41(2):235-44. PubMed ID: 17682710
    [Abstract] [Full Text] [Related]

  • 18. Variation in random amplified polymorphic DNA (RAPD) profiles specific to fluconazole-resistant and -sensitive strains of Candida albicans.
    Jain P, Khan ZK, Bhattacharya E, Ranade SA.
    Diagn Microbiol Infect Dis; 2001 Nov 25; 41(3):113-9. PubMed ID: 11750163
    [Abstract] [Full Text] [Related]

  • 19. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H, Cao YY, Xu Z, Zhao JX, Gao PH, Qin XF, Jiang YY.
    Antimicrob Agents Chemother; 2006 Mar 25; 50(3):1096-9. PubMed ID: 16495278
    [Abstract] [Full Text] [Related]

  • 20. Resistant mechanisms of Candida albicans to fluconazole.
    Wang W, Li R, Wang D, Li S, Zhu L, Wang X, Wan Z, Zhai W.
    Chin Med J (Engl); 1999 May 25; 112(5):466-71. PubMed ID: 11593521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.